Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2200]
News [4515]
Articles [113]
Editorials [23]
Conferences [175]
elearning [18]
Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R...
Dr Ajai Chari - Mount Sinai School of Medicine, New York, USA
Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma ( Dr Ajai Chari - Mount Sinai School of Medicine, New York, USA )
20 Dec 2022
What is required to advance data ethics, data sharing, and Open Science across...
Dr Priya Kumari - Regional Cancer Centre Trivandrum, Trivandrum, India
What is required to advance data ethics, data sharing, and Open Science across LMICs ( Dr Priya Kumari - Regional Cancer Centre Trivandrum, Trivandrum, India )
20 Dec 2022
Breast cancer in elderly patients: a clinicopathological review of a Nigerian...
Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀...
Breast cancer in elderly patients: a clinicopathological review of a Nigerian database ( Dr Funmilola Wuraola - Obafemi Awolowo University Teaching Hospital, Ilé-Ifẹ̀, Nigeria )
15 Dec 2022
An analysis of the worldwide utilisation of haematopoietic stem cell...
Dr Molly Tokaz - Fred Hutchinson Cancer Center, Seattle, USA
An analysis of the worldwide utilisation of haematopoietic stem cell transplantation for acute myeloid leukaemia ( Dr Molly Tokaz - Fred Hutchinson Cancer Center, Seattle, USA )
14 Dec 2022
Opinion: Premature regulatory approval by the FDA
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Opinion: Premature regulatory approval by the FDA ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
13 Dec 2022
HER2DX confirms the ability of the test to predict long-term survival and...
Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain
HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )
9 Dec 2022
The future of precision oncology
Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The future of precision oncology ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022
The concept of pan-tumour therapeutics
Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany
The concept of pan-tumour therapeutics ( Dr Benedikt Westphalen - Comprehensive Cancer Center München, Munich, Germany )
7 Dec 2022
Access to Oncology Medicines Coalition - The Medicines Patent Pool
Charles Gore - Medicines Patent Pool, Geneva, Switzerland
Access to Oncology Medicines Coalition - The Medicines Patent Pool ( Charles Gore - Medicines Patent Pool, Geneva, Switzerland )
1 Dec 2022
Cloud software for helping build quality assurance in radiotherapy
Prof Richard Sullivan, Dr Philippa Lewis and Dr Thea Johnson
Cloud software for helping build quality assurance in radiotherapy ( Prof Richard Sullivan, Dr Philippa Lewis and Dr Thea Johnson )
23 Nov 2022
ARCHERY trial: Testing AI for radiotherapy
Prof Richard Sullivan and Dr Ajay Aggarwal
ARCHERY trial: Testing AI for radiotherapy ( Prof Richard Sullivan and Dr Ajay Aggarwal )
23 Nov 2022
Addressing women’s cancers: an economic evaluation of breast and cervical...
Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya
Addressing women’s cancers: an economic evaluation of breast and cervical cancer interventions in Kenya ( Dr Mary Nyangasi - Head of the National Cancer Control Programme, Nairobi, Kenya )
23 Nov 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation